425 related articles for article (PubMed ID: 32418059)
21. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis.
Guo F; Nimmanapalli R; Paranawithana S; Wittman S; Griffin D; Bali P; O'Bryan E; Fumero C; Wang HG; Bhalla K
Blood; 2002 May; 99(9):3419-26. PubMed ID: 11964312
[TBL] [Abstract][Full Text] [Related]
22. Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-α and chemotherapeutic gemcitabine-induced necroptosis.
Akara-Amornthum P; Lomphithak T; Choksi S; Tohtong R; Jitkaew S
PLoS One; 2020; 15(1):e0227454. PubMed ID: 31914150
[TBL] [Abstract][Full Text] [Related]
23. Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosis.
Cristofanon S; Abhari BA; Krueger M; Tchoghandjian A; Momma S; Calaminus C; Vucic D; Pichler BJ; Fulda S
Cell Death Dis; 2015 Apr; 6(4):e1724. PubMed ID: 25880091
[TBL] [Abstract][Full Text] [Related]
24. MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death.
Jaco I; Annibaldi A; Lalaoui N; Wilson R; Tenev T; Laurien L; Kim C; Jamal K; Wicky John S; Liccardi G; Chau D; Murphy JM; Brumatti G; Feltham R; Pasparakis M; Silke J; Meier P
Mol Cell; 2017 Jun; 66(5):698-710.e5. PubMed ID: 28506461
[TBL] [Abstract][Full Text] [Related]
25. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
Ng CP; Bonavida B
Mol Cancer Ther; 2002 Oct; 1(12):1051-8. PubMed ID: 12481428
[TBL] [Abstract][Full Text] [Related]
26. A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells.
Petrucci E; Pasquini L; Petronelli A; Saulle E; Mariani G; Riccioni R; Biffoni M; Ferretti G; Benedetti-Panici P; Cognetti F; Scambia G; Humphreys R; Peschle C; Testa U
Gynecol Oncol; 2007 May; 105(2):481-92. PubMed ID: 17292950
[TBL] [Abstract][Full Text] [Related]
27. Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells.
Fandy TE; Shankar S; Srivastava RK
Mol Cancer; 2008 Jun; 7():60. PubMed ID: 18590557
[TBL] [Abstract][Full Text] [Related]
28. Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death.
Moriwaki K; Bertin J; Gough PJ; Orlowski GM; Chan FK
Cell Death Dis; 2015 Feb; 6(2):e1636. PubMed ID: 25675296
[TBL] [Abstract][Full Text] [Related]
29. Design of small-molecule peptidic and nonpeptidic Smac mimetics.
Sun H; Nikolovska-Coleska Z; Yang CY; Qian D; Lu J; Qiu S; Bai L; Peng Y; Cai Q; Wang S
Acc Chem Res; 2008 Oct; 41(10):1264-77. PubMed ID: 18937395
[TBL] [Abstract][Full Text] [Related]
30. Requirement of nuclear factor κB for Smac mimetic-mediated sensitization of pancreatic carcinoma cells for gemcitabine-induced apoptosis.
Stadel D; Cristofanon S; Abhari BA; Deshayes K; Zobel K; Vucic D; Debatin KM; Fulda S
Neoplasia; 2011 Dec; 13(12):1162-70. PubMed ID: 22241962
[TBL] [Abstract][Full Text] [Related]
31. The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer.
Hashim YM; Vangveravong S; Sankpal NV; Binder PS; Liu J; Goedegebuure SP; Mach RH; Spitzer D; Hawkins WG
J Exp Clin Cancer Res; 2017 Jan; 36(1):14. PubMed ID: 28095907
[TBL] [Abstract][Full Text] [Related]
32. SAHA overcomes FLIP-mediated inhibition of SMAC mimetic-induced apoptosis in mesothelioma.
Crawford N; Stasik I; Holohan C; Majkut J; McGrath M; Johnston PG; Chessari G; Ward GA; Waugh DJ; Fennell DA; Longley DB
Cell Death Dis; 2013 Jul; 4(7):e733. PubMed ID: 23868066
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways.
Derakhshan A; Chen Z; Van Waes C
Clin Cancer Res; 2017 Mar; 23(6):1379-1387. PubMed ID: 28039268
[TBL] [Abstract][Full Text] [Related]
34. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
Bockbrader KM; Tan M; Sun Y
Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
[TBL] [Abstract][Full Text] [Related]
35. Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL).
Xu X; Kalac M; Markson M; Chan M; Brody JD; Bhagat G; Ang RL; Legarda D; Justus SJ; Liu F; Li Q; Xiong H; Ting AT
Cell Death Dis; 2020 Feb; 11(2):94. PubMed ID: 32024820
[TBL] [Abstract][Full Text] [Related]
36. Synergistic Effects of a Smac Mimetic with Doxorubicin Against Human Osteosarcoma.
Kamata E; Kawamoto T; Ueha T; Hara H; Fukase N; Minoda M; Morishita M; Takemori T; Fujiwara S; Nishida K; Kuroda R; Kurosaka M; Akisue T
Anticancer Res; 2017 Nov; 37(11):6097-6106. PubMed ID: 29061790
[TBL] [Abstract][Full Text] [Related]
37. Smac mimetic sensitizes renal cell carcinoma cells to interferon-α-induced apoptosis.
Reiter M; Eckhardt I; Haferkamp A; Fulda S
Cancer Lett; 2016 May; 375(1):1-8. PubMed ID: 26912071
[TBL] [Abstract][Full Text] [Related]
38. Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro-inflammatory "FADDosome" Complex upon TRAIL Stimulation.
Henry CM; Martin SJ
Mol Cell; 2017 Feb; 65(4):715-729.e5. PubMed ID: 28212752
[TBL] [Abstract][Full Text] [Related]
39. The LEF1/CYLD axis and cIAPs regulate RIP1 deubiquitination and trigger apoptosis in selenite-treated colorectal cancer cells.
Wu P; Shi KJ; An JJ; Ci YL; Li F; Hui KY; Yang Y; Xu CM
Cell Death Dis; 2014 Feb; 5(2):e1085. PubMed ID: 24577083
[TBL] [Abstract][Full Text] [Related]
40. SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2.
Eytan DF; Snow GE; Carlson S; Derakhshan A; Saleh A; Schiltz S; Cheng H; Mohan S; Cornelius S; Coupar J; Sowers AL; Hernandez L; Mitchell JB; Annunziata CM; Chen Z; Van Waes C
Cancer Res; 2016 Sep; 76(18):5442-5454. PubMed ID: 27469115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
